Aarti Drugs
29 April, 2024 13:31 BSE: 524348
NSE: AARTIDRUGSISIN: INE767A01016
Start SIP in Aarti Drugs
Start SIPAarti Drugs Performance
Day Range
- Low 504
- High 514
52 Week Range
- Low 414
- High 646
- Open Price505
- Previous Close504
- Volume93137
Aarti Drugs Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 538 | 578 | 592 | 696 |
Operating Expenses Qtr Cr | 478 | 512 | 520 | 608 |
Operating Profit Qtr Cr | 60 | 65 | 72 | 89 |
Depreciation Qtr Cr | 12 | 12 | 12 | 12 |
Interest Qtr Cr | 7 | 8 | 8 | 8 |
Tax Qtr Cr | 11 | 12 | 14 | 16 |
Net Profit Qtr Cr | 32 | 35 | 40 | 53 |
Aarti Drugs Technicals
EMA & SMA
Current Price
₹509.1
+4.95 (0.98%)
- Bullish Moving Average
- ___
- 15
- Bearish Moving Average
- ___
- 1
- 20 Day
- ₹490.82
- 50 Day
- ₹490.58
- 100 Day
- ₹495.96
- 200 Day
- ₹495.52
- 20 Day
- ₹486.96
- 50 Day
- ₹490.09
- 100 Day
- ₹499.30
- 200 Day
- ₹516.52
Aarti Drugs Resistance and Support
PIVOT
₹501.87
Resistance | |
---|---|
First Resistance | 507.73 |
Second Resistance | 511.32 |
Third Resistance | 517.18 |
RSI | 59.25 |
MFI | 77.99 |
MACD Single Line | 4.13 |
MACD | 6.20 |
Support | |
---|---|
First Resistance | 498.28 |
Second Resistance | 492.42 |
Third Resistance | 488.83 |
Aarti Drugs Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 85,943 | 4,640,922 | 54 |
Week | 145,206 | 5,422,007 | 37.34 |
1 Month | 229,001 | 9,182,942 | 40.1 |
6 Month | 320,359 | 12,433,147 | 38.81 |
Aarti Drugs Result Highlights
Aarti Drugs Synopsis
NSE-Medical-Diversified
Aarti Drugs Ltd is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 2497.97 Cr. and Equity Capital is Rs. 92.60 Cr. for the Year ended 31/03/2023. Aarti Drugs Ltd. is a Public Limited Listed company incorporated on 28/09/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L37060MH1984PLC055433 and registration number is 055433.Market Cap | 4,682 |
Sales | 2,404 |
Shares in Float | 3.95 |
No of funds | 85 |
Yield | 0.2 |
Book Value | 4.19 |
U/D Vol ratio | 1.2 |
LTDebt / Equity | 15 |
Alpha | -0.02 |
Beta | 0.91 |
Aarti Drugs
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 57.13% | 57.47% | 58.56% | 58.7% |
Mutual Funds | 5.08% | 5.18% | 5.22% | 4.63% |
Insurance Companies | 0.08% | 0.08% | 0.1% | 0.08% |
Foreign Portfolio Investors | 2.56% | 2.1% | 2.33% | 1.97% |
Financial Institutions/ Banks | ||||
Individual Investors | 25.12% | 25.84% | 24.65% | 25.35% |
Others | 10.03% | 9.33% | 9.14% | 9.27% |
Aarti Drugs Management
Name | Designation |
---|---|
Mr. Chandrakant V Gogri | Chairman Emeritus |
Mr. Prakash M Patil | Chairman & M.D & CEO |
Mr. Rashesh C Gogri | Managing Director |
Mr. Harshit M Savla | Joint Managing Director |
Mr. Harit P Shah | Executive Director |
Mr. Uday M Patil | Executive Director |
Mrs. Neha R Gada | Independent Director |
CA. Navin C Shah | Independent Director |
Dr. Krishnacharya G Akamanchi | Independent Director |
Prof. Bhaskar N Thorat | Independent Director |
Mrs. Priti P Savla | Independent Director |
Mr. Ankit V Paleja | Independent Director |
Mr. Narendra J Salvi | Non Executive Director |
Aarti Drugs Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Aarti Drugs Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-05-03 | Audited Results | |
2024-01-24 | Quarterly Results & Interim Dividend | |
2023-10-19 | Quarterly Results | |
2023-07-21 | Quarterly Results & Buy Back | |
2023-04-29 | Audited Results |
Date | Purpose | Remarks |
---|---|---|
2024-02-06 | INTERIM | Rs.1.00 per share(10%)Interim Dividend |
2023-02-08 | INTERIM | Rs.1.00 per share(10%)Interim Dividend |
2022-02-10 | INTERIM | Rs.1.00 per share(10%)Interim Dividend |
Aarti Drugs FAQs
What is Share Price of Aarti Drugs ?
Aarti Drugs share price is ₹509 As on 29 April, 2024 | 13:17
What is the Market Cap of Aarti Drugs ?
The Market Cap of Aarti Drugs is ₹4680.4 Cr As on 29 April, 2024 | 13:17
What is the P/E ratio of Aarti Drugs ?
The P/E ratio of Aarti Drugs is 26 As on 29 April, 2024 | 13:17
What is the PB ratio of Aarti Drugs ?
The PB ratio of Aarti Drugs is 3.9 As on 29 April, 2024 | 13:17